Adherence to treatment is a decisive factor in antihypertensive therapy, which improves the prognosis of patients with hypertension. Low adherence to therapy is found in 50 % of AH patients, including those included in clinical trials, although in these individuals it is significantly higher than in actual outpatient clinical practice. Adherence to therapy is determined by factors that depend on the patient, are associated with the therapy, are associated with the disease, are dependent on doctors, and have socio-economic aspects. Factors depending on the patient include gender, age, level of education, income level, knowledge of the disease, practical skills, the psychological status of the patient and the presence of motivation for treatment. Among the factors of adherence associated with the therapy itself, the choice of the first drug, the number of drugs, the frequency of their intake, the regimen of administration, the development of side effects and the duration of the treatment being performed are essential.

1. 2018 ESH/ESC Guidelines for the management of arterial hypertension // Europ. Heart. J. −(2018) 00, 1−98.

2. Caro, J. J. Compliance as a function of initial choce of antihypertensive drug / J. J. Jackson, J. Speckman et al. // Am J. Hypertens. − 1997. − № 10. − 141A (Abstract).

3. Хохлов, А. Л. Анализ факторов, определяющих приверженность к антигипертензивной терапии / А. Л. Хохлов, Л. А. Лисенкова, А. А. Раков // Качественная клиническая практика. − 2003. − №4. – С. 59−66.

4. Метелица, В. И. «Каптоприл и качество жизни» : влияние антигипертензивных средств основных групп на качество жизни больных из различных популяций. Многоцентровое исследование / В. И. Метелица, С. Г. Дуда, Т. П. Островская и др. // Тер. архив. – 1996. – Том 68, № 4. С. 29−35.

5. Plaisted, C. L. The effect of dietary patterns on quality of life: A substudy of Dietary Approaches to Stop Hypertension trial / C. L. Plaisted, Lin P. H. et al. // J.AM.DIET.ASSOC. – 1999. − Vol. 99, № 8. – P. 84−89.

6. Bittar, N. Maintaining long-term control of blood pressure: the role of improved compliance / N. Bittar // Cliin Cardiol. − 1995. − Vol. 18. − P. III12–III16.

7. Gallup, G. JR., Cotugno, H. E. Preferences and practices of Americans and their physicians in antihypertensive therapy / G. JR. Gallup, H. E. Cotugno // Am J Med. − 1998. − Vol. 2, № 7. − P. 525−530.

8. Dusing, R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs// Drugs. − 2005. − Vol. 65. − P. 773–8.

9. Белоусов, Ю. Б. Основы клинической фармакологии и рациональной фармакотерапии: Руководство для практикующих врачей. – М.: Бионика. – 2002. – 368 с.

10. Гиляревский, С. Р., Орлов, В. А., Сычева, Е. Ю. Экономичные стратегии лечения в кардиологии / С. Р. Гиляревский, В. А. Орлов, Е. Ю. Сычева // Новости медицины и фармации. – 2007. – № 3. – С. 2.